Kangtai Bio (300601.SZ) released its first half year financial performance, with a net profit attributable to the parent company of 37.5327 million yuan, a decrease of 77.30%.

Zhtng Cijng APP News, Kangtai Biological (300601.SZ) released its interim report for the first half of 2025, with the company's operating income reaching 1.392 billion yuan, a year-on-year increase of 15.81%. The net profit attributable to the shareholders of the listed company was 37.5327 million yuan, a year-on-year decrease of 77.30%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 18.4586 million yuan, a year-on-year decrease of 84.85%. The basic earnings per share were 0.03 yuan.